Rothschild Investment LLC’s Corcept Therapeutics CORT Stock Holding History

Rothschild Investment LLC’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$29.2K	Sell	725 -114	-14%	-$4.26K	﹤0.01%	1276
2025 Q4	$29.2K	Sell	839 -116	-12%	-$9.11K	﹤0.01%	1198
2025 Q3	$79.4K	Buy	+955	New	+$69.1K	﹤0.01%	864
2025 Q2	–	Sell	-125	Closed	-$14.3K	–	3058
2025 Q1	$14.3K	Buy	125 +40	+47%	+$2.44K	﹤0.01%	1084
2024 Q4	$4.28K	Buy	85 +10	+13%	+$524	﹤0.01%	1406
2024 Q3	$3.47K	Buy	75 +40	+114%	+$1.42K	﹤0.01%	1440
2024 Q2	$1.14K	Buy	35 +30	+600%	+$822	﹤0.01%	1594
2024 Q1	$126	Buy	+5	New	+$118	﹤0.01%	2056

Other funds holding CORT

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Ingalls & Snyder LLC New York $2.82B AUM 21.61% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Parallel Advisors San Francisco, California $5.55B AUM 17.89% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Trust Advisors

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return